The Pharmaceutical Journal
Vol 268 No 7196 p597-604
4 May 2002

This article
Reprint
Photocopy

News summary

New oxazolidinone shows potential

AstraZeneca's new antimicrobial oxazolidinone, AZD2563, shows potential for use in combination with other antibiotics, new data shows.

Data presented at the 12th European Congress of Clinical Microbiology and Infectious Diseases in Milan, last week, showed that the antibacterial activity of AZD2563 was not reduced when tested in combination with other antibiotics in vitro.